AtriCure Inc (NAS:ATRC)
$ 23.14 0.51 (2.25%) Market Cap: 1.12 Bil Enterprise Value: 1.06 Bil PE Ratio: 0 PB Ratio: 2.45 GF Score: 72/100

AtriCure Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 10, 2022 / 12:30PM GMT
Release Date Price: $66.39 (+7.74%)
Robert Justin Marcus
JPMorgan Chase & Co, Research Division - Analyst

Good morning, and welcome to the 2022 JPMorgan Healthcare Conference. I'm happy to kick it off this morning with AtriCure. I'm Robbie Marcus, Med-tech Analyst at JPMorgan. And very happy to have the CEO, Mike Carrel from AtriCure. And joining us later for Q&A will be Angie Wirick, the CFO for AtriCure. Mike, I'll hand it over to you in just a second, but as a reminder, I'll be -- you'll hear this a lot this week. Feel free to e-mail me or chat me on Bloomberg with any questions you have for management during the Q&A session. You can also go on the conference web page and submit a question to me as well. But with that, Mike, I'll turn it over to you and join you for Q&A in a little bit.

Michael H. Carrel
AtriCure, Inc. - CEO, President & Director

That sounds great. Well, thanks, Robbie, and welcome, everybody. I know it is early morning for those of you on the West Coast. We'd all love to be together at JPMorgan. I think that's something that I always look forward to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot